Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know
SALT LAKE CITY, March 17, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug...
2 High-Flying Stocks with Competitive Advantages and 1 We Brush Off
Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc
3 Reasons to Sell MYGN and 1 Stock to Buy Instead
Myriad Genetics (MYGN) Shares Skyrocket, What You Need To Know
3 Stocks Under $10 We Keep Off Our Radar
NEW YORK , March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices:
2 Unprofitable Stocks on Our Buy List and 1 We Brush Off
Myriad Genetics (MYGN) Stock Trades Up, Here Is Why